(19)
(11) EP 4 400 130 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
16.10.2024 Bulletin 2024/42

(43) Date of publication A2:
17.07.2024 Bulletin 2024/29

(21) Application number: 24172335.2

(22) Date of filing: 18.02.2016
(51) International Patent Classification (IPC): 
A61M 5/172(2006.01)
A61M 5/158(2006.01)
 A61M 5/142(2006.01)
A61M 5/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 2005/1585; A61M 5/14248; A61M 5/1723; A61M 2005/1402; A61M 2005/14252; A61M 2005/14208; A61M 2005/1726
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 18.02.2015 US 201562117937 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
20181024.9 / 3733227
16753053.4 / 3258991

(71) Applicant: Insulet Corporation
Acton MA 01720 (US)

(72) Inventor:
  • SCHMID, Kevin G.
    Boxford, MA 01921 (US)

(74) Representative: Peterreins Schley 
Patent- und Rechtsanwälte PartG mbB Hermann-Sack-Straße 3
80331 München
80331 München (DE)

   


(54) FLUID DELIVERY AND INFUSION DEVICES


(57) A medical device comprising an infusion device comprising a fluid reservoir to contain a therapeutic fluid and a transcutaneous access tool fluidly coupled to the fluid reservoir, the transcutaneous access tool configured to deliver the therapeutic fluid subcutaneously to a patient; wherein the infusion device operates in a stand-by mode prior to the therapeutic fluid being introduced into the fluid reservoir; wherein the infusion device operates to deploy the transcutaneous access tool within a predetermined deployment time period upon filling the fluid reservoir to a predetermined fill level with the therapeutic fluid.







Search report












Search report